Carregant...

Therapy in hereditary angioneurotic oedema

Two branches of a family suffering from hereditary angioneurotic oedema underwent trials of therapy of ε-amino caproic-acid (EACA) to ascertain the optimum dosage required to alleviate symptoms without giving rise to unpleasant side effects. It was found that children under 11 years tolerated 3 g/da...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autor principal: Gwynn, C. M.
Format: Artigo
Idioma:Inglês
Publicat: 1974
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1648996/
https://ncbi.nlm.nih.gov/pubmed/4213636
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!